New Key Statistics Module, Z-Score and F-Score
NAS:CLOV Key Ratios
Market Cap $ M | 1,375.50 |
Enterprise Value $ M | 943.25 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.05 |
Price/Sales | 0.78 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,695.00 |
EPS (TTM) $ | -0.27 |
Beneish M-Score | -2.76 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -7.42 |
EV-to-EBITDA | -7.53 |
PEG | -- |
Shares Outstanding M | 497.47 |
Net Margin (%) | -7.30 |
Operating Margin % | -6.05 |
Pre-tax Margin (%) | -7.55 |
Quick Ratio | 1.69 |
Current Ratio | 1.69 |
ROA % (ttm) | -14.61 |
ROE % (ttm) | -39.75 |
ROIC % (ttm) | -30.08 |
Dividend Yield % | -- |
Altman Z-Score | 0.04 |
CLOV Number of Guru Trades
CLOV Volume of Guru Trades
Gurus Latest Trades with NAS:CLOV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CLOV is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Clover Health Investments Corp Insider Transactions
No Available Data
News about NAS:CLOV
Total 0- 1